EE200200440A - Estramustiinfosfaadi või selle metaboliidi kasutamine taksaani toimimisvõimet suurendava ravimi valmistamiseks, toimeaine ning seda sisaldav kombineeritud preparaat - Google Patents
Estramustiinfosfaadi või selle metaboliidi kasutamine taksaani toimimisvõimet suurendava ravimi valmistamiseks, toimeaine ning seda sisaldav kombineeritud preparaatInfo
- Publication number
- EE200200440A EE200200440A EEP200200440A EEP200200440A EE200200440A EE 200200440 A EE200200440 A EE 200200440A EE P200200440 A EEP200200440 A EE P200200440A EE P200200440 A EEP200200440 A EE P200200440A EE 200200440 A EE200200440 A EE 200200440A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- taxane
- metabolite
- active ingredient
- estramustine phosphate
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960004750 estramustine phosphate Drugs 0.000 title 1
- ADFOJJHRTBFFOF-RBRWEJTLSA-N estramustine phosphate Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)OP(O)(O)=O)[C@@H]4[C@@H]3CCC2=C1 ADFOJJHRTBFFOF-RBRWEJTLSA-N 0.000 title 1
- 239000002207 metabolite Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0003201.1A GB0003201D0 (en) | 2000-02-11 | 2000-02-11 | Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| PCT/EP2001/001088 WO2001058455A1 (en) | 2000-02-11 | 2001-02-01 | Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200440A true EE200200440A (et) | 2003-12-15 |
Family
ID=9885436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200440A EE200200440A (et) | 2000-02-11 | 2001-02-01 | Estramustiinfosfaadi või selle metaboliidi kasutamine taksaani toimimisvõimet suurendava ravimi valmistamiseks, toimeaine ning seda sisaldav kombineeritud preparaat |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20030153539A1 (et) |
| EP (1) | EP1267889A1 (et) |
| JP (1) | JP2003524645A (et) |
| KR (1) | KR20020089345A (et) |
| CN (1) | CN1398185A (et) |
| AU (1) | AU3022901A (et) |
| BR (1) | BR0108283A (et) |
| CA (1) | CA2398840A1 (et) |
| EA (1) | EA200200848A1 (et) |
| EE (1) | EE200200440A (et) |
| GB (1) | GB0003201D0 (et) |
| HK (1) | HK1049967A1 (et) |
| MX (1) | MXPA02007677A (et) |
| NZ (1) | NZ521061A (et) |
| WO (1) | WO2001058455A1 (et) |
| ZA (1) | ZA200206806B (et) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1769795B1 (en) * | 2001-12-03 | 2013-07-24 | Bayer HealthCare LLC | Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| RU2341296C2 (ru) | 2002-05-24 | 2008-12-20 | Энджиотек Интернэшнл Аг | Композиции и способы покрытия медицинских имплантатов |
| SE0203137D0 (sv) * | 2002-10-24 | 2002-10-24 | Karolinska Innovations Ab | Drug target in cancer therapy |
| CN100340296C (zh) * | 2005-02-03 | 2007-10-03 | 山东蓝金生物工程有限公司 | 一种抗癌体内植入剂 |
| WO2007140299A2 (en) * | 2006-05-25 | 2007-12-06 | Bristol-Myers Squibb Company | Use of ixabepilone in combination with cyp3a4 inhibitors for pharmaceuticals |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE196844T1 (de) * | 1996-05-22 | 2000-10-15 | Protarga Inc | Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten |
| AU750010B2 (en) * | 1998-03-27 | 2002-07-11 | Pharmacia & Upjohn Company | Methods to potentiate intravenous estramustine phosphate |
| US6436913B1 (en) * | 2000-07-25 | 2002-08-20 | Pharmacia & Upjohn Company | Use of estramustine phosphate in the treatment of bone metastasis |
| US6541509B2 (en) * | 2000-09-15 | 2003-04-01 | Albert Einstein College Of Medicine Of Yeshiva University | Method for treating neoplasia using combination chemotherapy |
-
2000
- 2000-02-11 GB GBGB0003201.1A patent/GB0003201D0/en not_active Ceased
-
2001
- 2001-02-01 WO PCT/EP2001/001088 patent/WO2001058455A1/en not_active Application Discontinuation
- 2001-02-01 BR BR0108283-3A patent/BR0108283A/pt not_active IP Right Cessation
- 2001-02-01 EA EA200200848A patent/EA200200848A1/ru unknown
- 2001-02-01 NZ NZ521061A patent/NZ521061A/en unknown
- 2001-02-01 EP EP01902382A patent/EP1267889A1/en not_active Withdrawn
- 2001-02-01 US US10/182,728 patent/US20030153539A1/en not_active Abandoned
- 2001-02-01 CA CA002398840A patent/CA2398840A1/en not_active Abandoned
- 2001-02-01 EE EEP200200440A patent/EE200200440A/et unknown
- 2001-02-01 KR KR1020027010359A patent/KR20020089345A/ko not_active Application Discontinuation
- 2001-02-01 MX MXPA02007677A patent/MXPA02007677A/es unknown
- 2001-02-01 JP JP2001557565A patent/JP2003524645A/ja not_active Withdrawn
- 2001-02-01 AU AU30229/01A patent/AU3022901A/en not_active Abandoned
- 2001-02-01 CN CN01804826A patent/CN1398185A/zh active Pending
-
2002
- 2002-08-26 ZA ZA200206806A patent/ZA200206806B/en unknown
-
2003
- 2003-03-28 HK HK03102235.8A patent/HK1049967A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003524645A (ja) | 2003-08-19 |
| HK1049967A1 (zh) | 2003-06-06 |
| EA200200848A1 (ru) | 2002-12-26 |
| CA2398840A1 (en) | 2001-08-16 |
| WO2001058455A1 (en) | 2001-08-16 |
| EP1267889A1 (en) | 2003-01-02 |
| CN1398185A (zh) | 2003-02-19 |
| GB0003201D0 (en) | 2000-04-05 |
| KR20020089345A (ko) | 2002-11-29 |
| AU3022901A (en) | 2001-08-20 |
| NZ521061A (en) | 2005-01-28 |
| BR0108283A (pt) | 2002-10-29 |
| US20030153539A1 (en) | 2003-08-14 |
| ZA200206806B (en) | 2004-02-26 |
| MXPA02007677A (es) | 2002-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1178786A4 (en) | PHARMACOLOGICALLY ACTIVE PROTEIN STABILIZING AGENTS; METHODS OF MANUFACTURE AND METHODS OF USE | |
| AU5367501A (en) | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof | |
| AU3076700A (en) | 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient | |
| SI1478339T1 (sl) | Farmacevtske formulacije antineoplastičnih sredstev, zlasti temozolomida, postopki za pripravo in uporabo le-teh | |
| DE60131760D1 (de) | Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform | |
| IL219671A0 (en) | 1,2- benzoxazoles and use thereof in the preparation of a medicament | |
| PL376154A1 (en) | Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient | |
| ID22565A (id) | Penggunaan nanodispersi dalam formulasi akhir obat | |
| HUP0302949A3 (en) | Active ingredient combinations comprising insecticidal and acaricidal properties and use thereof | |
| MXPA03001824A (es) | Combinaciones de productos activos con propiedades insecticidas y acaricidas. | |
| IS5662A (is) | Þíenýlasólýlalkoxýetanamín, framleiðsla þeirra ognotkun sem lyf | |
| AU2001282119A1 (en) | Active ingredient combinations with insecticidal and acaricidal properties | |
| AU2001291781A1 (en) | Active ingredient combinations comprising insecticidal and acaricidal properties | |
| AU2002335046A1 (en) | The use of proton sequestering agents in drug formulations | |
| EE04490B1 (et) | Ühend, selle valmistamise meetod ning kasutamine meditsiinis | |
| AU2001234114A1 (en) | Drugs containing combined active ingredients | |
| AR025235A1 (es) | FORMULACIoN DE UNA SUSPENSIoN ACUOSA ESTABLE ECTOPARASITICIDA QUE COMPRENDE ESPINOSINA, ARTíCULO DE FABRICACIoN QUE LA COMPRENDE Y SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO | |
| FR2809730B1 (fr) | Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique | |
| FR2804430B1 (fr) | Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| AU2001278772A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
| EE200200493A (et) | Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon | |
| HRP20040171A2 (en) | Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof | |
| WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof | |
| EE200200440A (et) | Estramustiinfosfaadi või selle metaboliidi kasutamine taksaani toimimisvõimet suurendava ravimi valmistamiseks, toimeaine ning seda sisaldav kombineeritud preparaat |